Viral Conjunctivitis Drugs Market
According to Intent Market Research, the Viral Conjunctivitis Drugs Market is expected to grow from USD 1.1 billion in 2024-e at a CAGR of 11.5% to touch USD 2.1 billion by 2030. The Viral Conjunctivitis Drugs Market is dominated by key players such as Allergan, Novartis International AG, Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., Roche Holding AG, Pfizer Inc., Teva Pharmaceuticals, Meda Pharmaceuticals, Bayer AG, Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Company, AbbVie Inc., Hikma Pharmaceuticals.